Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation: a Prospective, Multicenter, Cohort Study

NCT03749057 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT03749057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03749057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation: a Prospective, Multicenter, Cohort Study
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Phase 4
Overall status
Completed
Start date
November 20, 2018
Completion date
March 30, 2025
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction, tia